✦ LIBER ✦

Role of P-Glycoprotein in Pharmacokinetics

✍ Scribed by Dr Jiunn H. Lin, Masayo Yamazaki

Book ID: 119926463
Publisher: Springer International Publishing AG
Year: 2003
Tongue: English
Weight: 319 KB
Volume: 42
Category: Article
ISSN: 0312-5963
DOI: 10.2165/00003088-200342010-00003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of P-glycoprotein in pharmacokineti

Role of P-glycoprotein in pharmacokinetics and drug interactions of digoxin and β-methyldigoxin in rats

✍ Sachiyo Funakoshi; Teruo Murakami; Ryoko Yumoto; Yoshie Kiribayashi; Mikihisa Ta 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Digoxin and beta-methyldigoxin were evaluated pharmacokinetically in terms of P-glycoprotein (P-gp)-mediated drug interactions in rats. Evaluation was made by measuring the effects of a potent P-gp inhibitor (verapamil, cyclosporin A) on in vitro efflux transport of these compounds across the everte

Pharmacokinetic interaction between oral

Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin

✍ Dong-Hyun Choi; Joong-Hwa Chung; Jun-Shik Choi 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 153 KB

Effects of nifedipine on the pharmacokin

Effects of nifedipine on the pharmacokinetics of repaglinide in rats: Possible role of CYP3A4 and P-glycoprotein inhibition by nifedipine

✍ Choi, Jin-Seok; Choi, In; Choi, Dong-Hyun 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 285 KB

Effects of lovastatin on the pharmacokin

Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: Possible role of P-glycoprotein inhibition by lovastatin

✍ Soon-Pyo Hong; Kyoung-Sig Chang; Young-Youp Koh; Dong-Hyun Choi; Jun-Shik Choi 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 208 KB

Individual and combined roles of CYP3A,

Individual and combined roles of CYP3A, P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxel

✍ Robert A.B. van Waterschoot; Jurjen S. Lagas; Els Wagenaar; Hilde Rosing; Jos H. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 181 KB

## Abstract Docetaxel is one of the most widely used anticancer drugs. A major problem with docetaxel treatment, however, is the considerable interpatient variability in docetaxel exposure. Another disadvantage of the drug is that it has a very low oral bioavailability and can, therefore, only be a

Effects of the antioxidant baicalein on

Effects of the antioxidant baicalein on the pharmacokinetics of nimodipine in rats: a possible role of P-glycoprotein and CYP3A4 inhibition by baicalein

✍ Cho, Young-Ah; Choi, Jun-Shik; Burm, Jin-Pil 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 217 KB